We examined the characteristics of mitogens extracted from human benign prostatic hyperplasia and prostatic adenocarcinoma tissue. Although mitogens for fetal rat skin fibroblasts as well as for rat calvarial osteoblasts and osterosarcoma cells were found, distinct entities that acted selectively in cells of the osteoblast phenotype could be obtained by sequential reversephase high performance liquid chromatography. Two peptides with apparent molecular weights of 10,000 and 13,000 D were derived from hyperplastic tissue, whereas a single moiety of 10,000 D was obtained from malignant tissue. These entities increased cell numbers and alkaline phosphatase activity in osteoblastlike cells consistent with effects on both growth and differentiation. Prostatic peptides did not stimulate adenylate cyclase in osteosarcoma cells. Mitogenic activity selective for osteoblastlike cells was identified in postpubertal but not prepubertal normal prostate. The results demonstrate the existence of osteoblastic growth factors in prostatic tissue whose presence may accompany postpubertal development.
Introduction
Prostatic adenocarcinoma is virtually unique among malignancies with respect to its high association with osteoblastic metastases (1) . Earlier reports (1-4) described the presence of mitogens for cells of the osteoblast phenotype and for fibroblasts in both benign prostatic hyperplasia and prostatic adenocarcinoma tissue or cells. We previously found that mitogens extracted from hyperplastic and neoplastic prostatic tissue were trypsin-sensitive (3) and acid stable (unpublished observations), and that activity selective for cells of the osteoblast phenotype was basic (unpublished observations) and could be enriched by hydrophobic chromatography (3) . In the present study we have further examined the chromatographic characteristics of this material and assessed its effect on alkaline phosphatase activity, a parameter of osteoblast differentiation, and on adenylate cyclase activity in osteoblastlike cells. We also compared the mitogenic activity of hyperplastic and neoplastic prostatic tissues to that seen in normal and neoplastic nonprostatic tissues and to that present in normal preand postpubertal prostate.
Tissues. Five pools of human prostatic adenocarcinoma (CA),' and seven human benign prostatic hyperplasia (BPH) tissue biopsies obtained at surgery were kept frozen at -70'C until use. Gastric, colonic, and breast adenocarcinoma tissue were also obtained at the time of surgery and kept frozen at -70'C until use. These tissues were removed from patients who had no evidence of skeletal metastases or hypercalcemia. Normal postpubertal prostate and normal kidney, seminal vesicles, and gastric tissue were obtained from a 24-yr-old car accident victim at autopsy performed 6 h after death. Normal prepubertal prostate was obtained from a 7-yr-old car accident victim at autopsy performed 3 h after demise of the patient. A specimen of lymphoma was obtained at surgery from a 5-yr-old male without skeletal metastases but with clinical and biochemical features characteristic of the syndrome of humoral hypercalcemia of malignancy as previously described (5) .
The Leydig cell tumor (Rice H-500) that produces hypercalcemia in Fischer rats (6) Growth factors. Highly purified mouse epidermal growth factor (EGF) and bovine pituitary (basic) fibroblast growth factor (FGF) were from Sigma Chemical Co., St. Louis, MO. Platelet-derived growth factor (PDGF) was from Bethesda Research Laboratories, Gaithersburg, MD. Insulinlike growth factor (IGF) was a mixture of 67% IGF-I and 33% IGF-II. The activity of this preparation was 7,000 ng-equivalents/ml relative to an insulin standard in a radioreceptor bioassay and was kindly supplied by Drs. H. J. Guyda, C. Polychronakos, and B. I. Posner, McGill University, Montreal, Quebec, Canada.
Initial extraction procedures. Tumor tissue was extracted, as previously described (3, 7) . Tissue was first homogenized at 0C in acetone (30 ml/g). The insoluble precipitate was then homogenized in n-hexane (30 ml/g), and the insoluble material from this procedure was homogenzied again in acetone (30 ml/g). The dried and defatted residue was then extracted in a mixture (40 ml/g) of Adenylate cyclase assays were performed in cloned rat osteosarcoma cells (UMR 108) (13) . At confluence, cells were incubated with 1 MCi [2-3H] adenine (16 Ci/mmol; 1MCi/Ml; New England Nuclear) for 2 h in I ml culture medium per well. Immediately before addition of agents to be tested, the medium was aspirated from the wells, and the cells were washed twice with 1 ml HBSS to remove excess [3Hjadenine.
Tumor extracts or hormones were dried in a Speed-Vac concentrator (Savant Instruments, Hicksville, NY) before assay and then added to the cells in 0.5 ml McCoy's SA medium (Gibco) containing 0.1% BSA, 0.2 mM 3-isobutyl-I-tnethylxanthine (Sigma Chemical Co.), and 10-6 M forskolin (Calbiochem-Behring Corp., La Jolla, CA). Bovine parathyroid hormone (PTH)-( 1-84), used as a standard in the assay, was purchased from Bachem Co., Torrance, CA. After incubation at 220C for 10 min, the reaction was stopped by aspiration ofthe hormone-medium mixture and immediate addition of0.5 ml of 10% trichloroacetic acid. - 
Results
Characterization ofmitogenic activity in BPH and cancer extracts. Reverse-phase HPLC of extracts of BPH yielded mitogenic activity in all three indicator cells. However, two regions in which mitogenic activity was demonstrable in fetal rat calvarial cells and in osteosarcoma cells, but not in fibroblasts, could be observed (Fig. 1) . In some prostatic extracts, only a single region of such bioactivity was found (Fig. 1) . After rechromatography of these regions on reverse-phase HPLC, homogeneous UV peaks were obtained which retained activity in cells ofthe osteoblast phenotype but failed to stimulate activity in fibroblasts (Fig. 2) . These peaks produced dose-dependent stimulation of [3H]thymidine incorporation ( dose-dependent increase in number (Fig. 4) of cells of the osteoblast phenotype. Additionally, graded doses ofthis material increased alkaline phosphatase activity in the osteoblastlike cells (Fig. 4) . Reverse-phase HPLC of prostatic cancer extracts also yielded activity mitogenic in the three indicator cells; however, a region of mitogenic activity selective for cells of the osteo- blast phenotype was seen as well with this tissue (Fig. 5) . Further chromatography of this region also yielded a homgeneous UV peak (Fig. 6 ) which produced a dose-dependent increase in
[3H]thymidine incorporation and in alkaline phosphatase activity ( Fig. 7 ) in osteoblastlike cells.
To assess the responsiveness to growth factors of the fibroblast population we used, the mitogenic effect of the known growth factors EGF, PDGF, IGF, and FGF was tested. Each known mitogen produced dose-dependent stimulation of
[3H]thymidine incorporation in the fibroblasts employed (Table I) was observed although PTH and extracts ofcancers associated with hypercalcemia were stimulatory (Table II) . The UV peaks, obtained from sequential reverse-phase HPLC, appeared homogenous by gel permeation HPLC (Fig.  8) . The earlier eluting peak, I-A, extracted from BPH tissue had an apparent 10,000 mol wt whereas the later eluting peak, I-B, had an apparent 13,000 mol wt. The material, II-C, obtained from a specimen of BPH from which only a single selective bioactive peak could be extracted, had an apparent 13,000 mol wt. The peak obtained from prostatic cancer tissue eluted with an apparent 10,000 mol wt.
Characterization ofmitogenic activity in control tissues and normal prostate. Although mitogenic activity for all three indicator cells could be extracted from malignant gastric, colonic, and breast tissue (collected and stored in a manner identical to that ofprostatic hyperplastic and malignant tissue) no activity selective for osteoblastlike cells could be resolved by reverse-phase HPLC analysis from these nonprostatic tissues (Fig. 9) .
. 80 Figure 7 . (Fig. 10) . However when normal adult prostatic tissue collected and handled in an identical manner was examined, a single region of activity selectively mitogenic for cells of the osteoblast phenotype was observed (Fig. 1 1) . This activity was not seen after chromatograhy of extracts of normal prepubertal prostate, although eluates active in all three cell types were obtained.
Discussion
Initial interest in the presence within prostatic tissue of growth factors for osteoblasts arose from the very high frequency, relative to other neoplasms, with which prostatic adenocarcinomas are associated with osteogenic metastases (1) . Subsequent work indeed identified osteoblast mitogens in extracts of human prostatic cancer tissue (1-3) and in one study (4) messenger RNA extracted from a human prostatic cancer cell line mary culture and a second an established malignant cell line, to examine selective activity relative to that in skin fibroblasts. We have found in this way that two mitogens for osteoblastlike cells may be obtained from hyperplastic tissue with estimated 10,000 and 13,000 mol wt, whereas a single mitogen for osteoblastlike cells with an apparent 10,000 mol wt was extractable from prostatic adenocarcinoma. Whether these two moieties are related as precursor and product or whether they are distinct entities will require further study. The mitogens appeared to increase cell proliferation, and at least one parameter of differentiated osteoblast function (alkaline phosphatase activity) was enhanced. Although growth factors generally do not employ the adenylate cyclase system for signal transduction, endocrine trophic factors such as thyroid-stimulating hormone are known to stimulate cyclic AMP in target tissues in addition to their effects on enhancing cell growth and differentiated function (15) . No significant increase in adenylate cyclase activity was seen in osteoblastlike cells in response to our prostatic mitogens, suggesting that our material does not employ this mechanism of action. This property also distinguishes our material from other peptides, produced by neoplastic tissue and capable of influencing osteoblastic activity, which stimulate adenylate cyclase and have been associated with a hypercalcemic bone-resorbing syndrome.
An increasing number of growth factors have been identified in recent years (16, 17) and many may be synthesized by multiple tissues. Consequently, the presence of mitogens in extracts of a variety ofneoplastic and normal tissues we examined was not an unexpected finding. Yet, most known growth factors fail to act selectively in the three mesodermal cell types we employed. This and other characteristics, such as apparent molecular weight, also appears to distinguish our human prostatic materials from the acidic prostate-derived growth factor for fibroblasts isolated from rat tissues (18) . Although we were unable to identify selective osteoblastlike mitogenic activity in prepubertal prostate, such activity was demonstrable in normal postpubertal tissue, suggesting the possibility of androgen dependence. In view of the higher skeletal mass in males relative to females and the acceleration of skeletal loss after menopause in females, a phenomenon without parallel in the male, the presence of androgen-dependent osseous growth factors in the male could be of major importance in understanding the mechanisms of several basic observations in skeletal physiology.
